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Background: We studied the ability of 4 single-breath gas washout (SBW) tests to measure immediate effects of airway clearance in children with
CF.
Methods: 25 children aged 4–16 years with CF performed pulmonary function tests to assess short-term variability at baseline and response to
routine airway clearance. Tidal helium and sulfur hexaﬂuoride (double-tracer gas: DTG) SBW, tidal capnography, tidal and vital capacity nitrogen
(N2) SBW and spirometry were applied. We analyzed the gasses' phase III slope (SnIII— normalized for tidal volume) and FEV1 from spirometry.
Results: SnIII from tidal DTG-SBW, SnIII from vital capacity N2-SBW, and FEV1 improved signiﬁcantly after airway clearance. From these tests,
individual change of SnIII from tidal DTG-SBW and FEV1 exceeded short-term variability in 10 and 6 children.
Conclusions: With the tidal DTG-SBW, an easy and promising test for peripheral gas mixing efﬁciency, immediate pulmonary function response
to airway clearance can be assessed in CF children.
© 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Children; Cystic ﬁbrosis; Respiratory function test; Physical therapy modalities; Pulmonary ventilation1. Introduction
Airway clearance regimens, e.g. short-acting bronchodilator
inhalation followed by chest physiotherapy (PT), are standard
of current routine care in cystic fibrosis (CF). Few studies have
attempted to measure treatment response in pulmonary function
[1–4]. The currently most promising pulmonary function testsAbbreviations: CF, cystic fibrosis; CO2, carbon dioxide; CR, coefficient o
repeatability (between-test repeatability); DTG, double-tracer gas: 26.3%
helium and 5% sulfur hexafluoride; FEV1, forced expiratory volume in one
second; He, helium; LCI, lung clearance index; ICC, intra-class correlation
coefficient (intra-test repeatability); MEF25–75, mean expiratory flow between
25 and 75% of expired volume; MBW, multiple-breath washout test; N2
nitrogen; PFT, pulmonary function test; PT, chest physiotherapy; SIII, slope o
alveolar phase III from gas washout curves; SnIII, tidal volume normalized
phase III slope from gas washout curves; SBW, single-breath washout; SF6
sulfur hexafluoride.
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,lished(PFTs) are the gas washout tests. These tests quantify the
efficiency of gas mixing (ventilation distribution homogeneity)
which may improve upon airway clearance [5–9]. The sulfur
hexafluoride (SF6) multiple-breath washout (MBW) technique
demonstrates changes in pulmonary function following four
weeks of hypertonic saline or dornase alpha inhalation inmild CF
lung disease [2,10]. However, immediate pulmonary function
changes seem more difficult to assess [11–15].
We have recently developed and validated a new tidal
single-breath washout (SBW) technique [16,17]. This SBW is
based on a tidal in- and exhalation of a double-tracer gas (DTG)
mixture containing helium (He) and SF6 during normal quiet
breathing. An increased (steeper) phase III slope, i.e. the slope
of phase III normalized for tidal volume (SnIIIDTG), implies
increased ventilation inhomogeneity near the acinar lung regions
[17]. Alternatively, the SnIII from carbon dioxide (CO2 —
capnography) or the SnIII from nitrogen (N2) SBW tests may
contain information on global ventilation inhomogeneity [18,19].
Our objective was to study the ability of these gas washout tests
to detect immediate pulmonary function changes upon routineby Elsevier B.V. All rights reserved.
Table 1
Characteristics of patients and interventions.
Age (years) 11.3 ± 3.5
Females/males (n) 15/10
ΔF508 homozygous (n) 12
Inhalation medication and chest physiotherapy
Hypertonic saline solution (3% or 6% NaCl) 14
Isotonic saline solution (0.9% NaCl) 11
Salbutamol 22
Ipratropium bromide/rhDNase/natriumcromoglycat 2/2/5
Positive end-expiratory pressure technique (PEP)/ flutter 22/3
Data are given as absolute counts, age is given as mean ± SD.
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washout tests performed at baseline and after airway clearance.
The primary end point was the change in SnIII upon intervention.
We assessed these changes in the whole study population based
on statistical thresholds (p b 0.05) and in individuals based on
clinical thresholds (N95% short-term variability). Secondary aims
were to compare SnIII changes with changes in forced expiratory
volume in one second (FEV1) and mean expiratory flow between
25% and 75% of expired volume (MEF25–75) from spirometry.
2. Methods
2.1. Study design
Twenty-five children aged 4–16 years attending the CF
outpatient clinic at the Children's University Hospital of Bern,
Switzerland, were recruited. CF was diagnosed clinically in
infancy. We conducted a pragmatic trial to study the ability of gas
washout tests in measuring response to every-day airway clearance
regimens (Fig. 1, Table 1). Children used their standard inhalation
and PT regimen as performed at home. First, all children inhaled
salbutamol or ipratropium bromide in saline solution for 15 min.
Second, children performed chest PT under the guidance of
pediatric CF physiotherapists for 25 min. Pulmonary function tests
(PFT) consisted of two repeats at baseline (PFT #1), one PFT (#2)
following inhalation and one PFT (#3) following both inhalation
and PT. The first two baseline tests were performed 15 min
apart to assess short-term repeatability between tests. The order
of assessments within each PFT occasion was (i) tidal DTG-SBW,
(ii) tidal capnography, (iii) tidal N2-SBW, (iv) vital capacity
N2-SBW, and (v) spirometry. In total, 590 SBWs were
successfully performed. To avoid possible training effects,
baseline tests were averaged for comparison with PFT following
interventions. The study (018/1) was approved by the Ethics
Committee of the Canton of Bern, Switzerland. The children's
assent was obtained and all parents or caregivers provided full
written informed consent for this study.Fig. 1. Flow chart of2.2. Pulmonary function tests
All tests were done by a single investigator (CA). We used
available hard- and software (Exhalyzer D®, Eco Medics AG,
Duernten, Switzerland) for all SBW tests as described previously
[16,17,20–22]. In brief, side- and main-stream ultrasonic flowme-
ters measure molar mass and tidal flow. The molar mass signal is
used for the DTG-SBW. N2 measured indirectly via side-stream
oxygen (O2) and main-stream CO2 sensors is used for the N2-
SBW tests. CO2 measured directly is used for capnography. The
DTG mixture contains 26.3% He and 5% SF6, 21% O2 and
balance N2 (Carbagas, Bern, Switzerland). This DTG mixture has
the same molar mass as air, such that the shape of the washout
curve can be attributed to He and SF6 [16,17]. The principle of this
new tidal DTG-SBW test is that the molar mass signal aggregates
the He and SF6 washout behavior, i.e. phase III slopes of He and
SF6 [16]. These inert gasses distribute similarly by convection in
the large central airways. Due to the differing molecular weight of
He and SF6, they distribute differently in the small peripheral
airways. DTG was applied for a single tidal inhalation prior to
exhalation back to functional residual capacity. Similarly, 100%
O2 was applied for N2-SBW during tidal breathing. Maneuvers for
vital capacity N2-SBWwere guided by visual incentives. CO2 was
measured prior to tidal SBW tests and used for capnography.the study design.
Fig. 2. a and b. Phase III slope fitting. Typical examples of gas washout tests in
a 13 year old girl with CF. The slope was fitted (least square method) to
alveolar phase III to describe the tidal washout curves of a (i) 26.3% helium and
5% sulfur hexafluoride (double-tracer gas — DTG) mixture, (ii) naturally
exhaled carbon dioxide (CO2 capnography), and (iii) the vital capacity nitrogen
(N2) washout curve following 100% oxygen inhalation. SIII was fitted between
65 and 95% expired volume for tidal gas washout tests (DTG, CO2) and
between 25 and 75% for N2 vital capacity gas washout tests. SIII was then
normalized (SnIII) for the tidal volume of each gas washout test.
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two minutes.
Phase III slope (SIII) analysis was done by a single investigator
(FS) using available software (LungSim, Numerical Modelling,
Thalwil, Switzerland) according to the recent consensus docu-
ment on inert gas washout testing and as previously described
[17,23]. Tidal SBW tests were selected if tidal volumes were
sufficiently large, i.e. phase III of the washout curve reflected
at least 50% of expired tidal volume. SIII was calculated
automatically by linear fit between 65 and 95% of expired
volume from tidal tests [24], and between 25 and 75% of expired
volume from the vital capacity N2-SBW [25,26]. The fit was
manually adjusted if necessary. SIII was multiplied (normalized)
with tidal volume (SnIII) to account for physiological differences
in breaths within and between subjects [25]. SnIII from DTG, N2,
and CO2washout curves was the primary measure (Fig. 2a and b).
SnIIIDTG mainly reflects acinar (diffusion–convection dependent)
ventilation inhomogeneity [27]. SnIIIDTG z-scores were derived
from a previous study in 52 healthy school-aged children from the
same population [17]. SnIIIN2 and SnIIICO2 are measures of
global ventilation inhomogeneity and gas exchange efficiency. In
general, a smaller, less steep slope (SnIII) upon airway clearance
reflects improved gas mixing efficiency [25]. Thus a decrease in
absolute SnIIIN2 or SnIIICO2 values would suggest improved
pulmonary function. Change of SnIIIDTG z-scores towards the
normal range (within two z-scores) also reflects improved
pulmonary function and gas mixing efficiency of both He and
SF6 [16,25].
Spirometry was performed using a handheld device (EasyOne,
ndd Medical Technologies, Zurich, Switzerland) according to
current standards [28]. Outcomes were FEV1 and MEF25–75.
z-Scores were derived from published reference data [29].
2.3. Statistics
All analyses were done using Stata™ (StataCorp. 2009.
Release 11. College Station, TX). We calculated sample size
using the airway clearance regimen as the main exposure and
SnIIIDTG as the primary outcome. We based our estimate on
published SnIIIDTG variability of 20.8% within a comparable
population. We estimated a treatment response of twice the
variability (41.6%). Assuming a two-sided significance level of
5% and a power of 80%, 23 study participants would be needed
to complete this study. We aimed to recruit 25 patients. To
assess intra-test repeatability at baseline, the intraclass correlation
coefficient (ICC) was calculated from a simple multilevel model
from baseline data. The ICC relates between-subject variance to
total variance, an ICC N0.8 suggests good repeatability.We chose
the ICC as we aimed to compare repeatability on untransformed
data measured on different scales, and to account the within-
subject variance to the varying degrees of variance between
subjects [30]. As PFT data were not normally distributed, we
described data by median (inter-quartile range — IQR) and
compared data by Wilcoxon matched-pairs signed-rank tests on
the group level. p-Values b0.05 were considered statistically
significant. On the individuals' level we estimated the significance
of observed changes in pulmonary function using the coefficientof repeatability (CR). The CR estimates the range of short-term
variability between tests explained by technical or physiological
factors which normally affect all physiological tests [31,32]. We
calculated the CR of SnIII, FEV1 andMEF25–75 from the first two
baseline PFTs, i.e. 1.96 ∗ standard deviations of differences
between measurements. Following the airway clearance interven-
tions, we considered any observed change in SnIII, FEV1 and
MEF25–75 greater than their CR as clinically significant.
3. Results
Ten boys and fifteen girls with CF were enrolled (Table 1).
Mean (SD) age was 11.3 (3.5) years. Tidal gas washout tests
and spirometry were obtained in all children except for one boy
at baseline. The vital capacity N2-SBW was achieved by 20
children during all PFTs (Fig. 1). Thus, complete tidal SBW and
spirometry data were available in 24 children and vital capacity
Fig. 3. Pulmonary function response on the group level. The normalized phase
III slope (SnIII) from the tidal double-tracer gas single-breath washout
(DTG-SBW), mean expiratory flow between 25% and 75% of expired volume
(MEF25–75), and forced expiratory volume in one second (FEV1) improved
comparing baseline pulmonary function (left box) and pulmonary function
following routine airway clearance regimes (right box) in 24 children. z-Scores
were derived from previous data [29]. p-Values were derived from Wilcoxon
matched-pairs signed-rank tests.
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for FEV1 (ICC = 0.96), MEF25–75 (ICC = 0.97) and SnIIIDTG
(ICC = 0.97), and good for tidal SnIIIN2 (ICC = 0.85). Tidal
SnIIICO2 (ICC = 0.69) and vital capacity SnIIIN2 (ICC = 0.67)
were more variable in children. At baseline, twelve children had
abnormal FEV1 (b−2 z-scores) and 22 children had abnormal
SnIIIDTG. In those 13 children with normal FEV1, SnIIIDTG was
abnormal in ten.
On the group level, the tidal DTG-SBW and the vital capacity
N2-SBW were the only gas washout tests detecting statistically
significant pulmonary function response (Table 2). Similarly
FEV1 and MEF25–75 improved (Fig. 3). Regarding the timing of
response, SnIIIN2 from vital capacity N2-SBW, and FEV1 and
MEF25–75 improved already after inhalation (2nd PFT). These
measures kept their level without further improvement following
chest PT (3rd PFT). Interestingly, the SnIIIDTG marginally
decreased (improved) after inhalation but significantly improved
following chest PT. Baseline SnIIIDTG median (IQR) was −66.0
(−168.5; −46.2) compared to −22.4 (−105.1; 57.2) mg/mol at
the 3rd PFT (p = 0.017). Measures of ventilation heterogeneity
were weakly or not interrelated, and FEV1 and MEF25–75 were
consistently correlated.
On the individuals' level, the size and direction of pulmonary
function response in relation to the short-term variability (CR)
were assessed. Pulmonary function responses were heteroge-
neous (Fig. 4). We observed both, smaller, less steep (improved)
and steeper (worsened) SnIII as well as increased (improved) and
decreased (worsened) FEV1 or MEF25–75 (Table 3). Clinical
significant response (change NCR) was evident in 13 children:
SnIIIDTG (n = 10), SnIIIN2 from tidal SBWN2 (n = 4), SnIIICO2
from tidal capnography (n = 1), MEF25–75 (n = 8), and FEV1
(n = 6). Change in pulmonary function was demonstrated by
more than one PFT in 6/13 children. Relevant change of
SnIIIDTG, FEV1 and MEF25–75 was present in six children. In
the other seven children, SnIIIDTG exclusively changed in four
children, and both FEV1 and MEF25–75 in three children.
Individual response in SnIIIN2 from vital capacity SBWN2 did
not exceed the CR.Table 2
Pulmonary function response assessed on the group level.
Pulmonary function tests Unit n Baseline CR P
Tidal breathing
DTG-SBW SnIII mg/mol 24 −66.0 (−168.5; −46.2) 65.3 −
SnIII z-Score 24 −3.3 (−5.4; −2.9) 1.3
Capnography SnIII % CO2 24 0.8 (0.6; 1.0) 0.5
N2-SBW SnIII % N2 24 6.5 (4.0; 8.9) 4.1
Vital capacity
N2-SBW SnIII % N2 20 8.7 (5.5; 12.5) 9.3
Spirometry FEV1 L 24 1.5 (1.3; 1.9) 0.3
FEV1 z-Score 24 −2.15 (−3.3; −1.1) 0.8
MEF25–75 L/s 24 1.3 (0.9; 1.8) 0.4
MEF25–75 z-Score 24 −2.5 (−4.0; −1.6) 0.9
Pulmonary function data are given as median (IQR) and compared between baseline
coefficient of repeatability (CR) reflects the 95% range of short-term variability b
(multiplied) by tidal volume; DTG: double-tracer gas (5% helium and 26.3% sulfur
mean expiratory flow between 25 and 75% of expired volume. Spirometry and DTGTo assess if the gas washout tests prove of higher value in a
sub-set of patients, we stratified children into those with mild
(normal baseline FEV1) and moderate CF lung disease (decreased
baseline FEV1 b−2 z-scores). In children with mild CF, SnIIIDTG
decrease was slightly greater compared to children with abnormal
FEV1 in whom SnIIIDTG tended to increase (p = 0.042).
Interestingly in the latter children with moderate CF lung disease,
pulmonary function response was better detected by the vital
capacity N2-SBW and spirometry: vital capacity SnIIIN2
decreased (p = 0.034) and FEV1 improved (p = 0.002) while it
did not change significantly in children with mild CF. This was
confirmed by multivariable regression analysis (data not shown)
adjusting for age, gender, and hypertonic vs. isotonic saline
solution inhalation.ost-inhalation p-Value Post-inhalation & physiotherapy p-Value
45.2 (−151.7; 89.1) 0.378 −22.4 (−105.1; 57.2) 0.017
−2.9 (−5.0; −0.2) 0.378 −2.5 (−4.1; −0.9) 0.018
0.8 (0.6; 1.0) 0.946 0.7 (0.6; 1.1) 0.731
5.4 (3.8; 8.5) 0.382 6.8 (4.2; 9.5) 0.376
7.0 (4.7; 12.0) 0.019 6.3 (4.4; 11.9) 0.009
1.7 (1.2; 2.0) 0.021 1.7 (1.2; 1.9) 0.033
−1.8 (−2.8; −0.9) 0.015 −2.0 (−3.0; −0.9) 0.051
1.2 (0.9; 1.9) 0.011 1.2 (1.0; 2.0) 0.027
−2.4 (−3.6; −1.0) 0.017 −2.4 (−3.6; −0.8) 0.031
and post-intervention using the Wilcoxon matched-pairs signed-rank test. The
etween tests. SBW: single-breath washout; SnIII: phase III slope normalized
hexafluoride); FEV1: forced expiratory volume in one second; and MEF25–75:
-SBW z-scores were calculated from published data [17,29].
Fig. 4. Pulmonary function response on the individuals' level. Pre- and post-treatment values of the normalized phase III slope (SnIII) from the tidal double-tracer gas
single-breath washout (DTG-SBW) and the classical vital capacity nitrogen SBW (upper panel), and mean expiratory flow between 25% and 75% of expired volume
(MEF25–75) and forced expiratory volume in one second (FEV1) from spirometry (lower panel). Baseline (left, dark gray circles), post-inhalation (middle, light gray
circles), and post-PT (right, light gray circles) data are given.
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4.1. Summary
This study shows that the new tidal DTG-SBW test can be used
to assess changes in gas mixing efficiency upon chest PT. This test
seems especially attractive in patients with mild CF lung disease.
The shape of the last third of the washout curve, the SnIIIDTG, is a
repeatable and sensitive outcome of the DTG-SBW. SnIIIDTG
statistically significantly decreased comparing baseline and post-
airway clearance values. In ten of 24 children, this change in
SnIIIDTG clearly exceeded the predefined clinical threshold (short-
term variability). The classical tests, spirometry and the vitalTable 3
Pulmonary function response assessed on the individuals' level.
Pulmonary function tests Unit n
Tidal DTG-SBW SnIII mg/mol 24
Tidal DTG-SBW SnIII z-Score 24
Tidal capnography SnIII % CO2 24
Tidal N2-SBW SnIII % N2 24
Vital capacity N2-SBW SnIII % N2 20
Spirometry FEV1 L 24
FEV1 z-Score 24
MEF25–75 L/s 24
MEF25–75 z-Score 24
Response in pulmonary function calculated as difference between baseline— post-in
inter-quartile range (IQR). The number of children in which individual PFT differen
differences between the two baseline PFTs). Flatter normalized phase III slopes (Sn
SBW: single-breath washout; DTG: double-tracer gas (5% helium and 26.3% sulfur
mean expiratory flow between 25 and 75% of expired volume.capacity N2-SBW, rather reflect improvement of ventilatory
capacity after bronchodilator inhalation. The latter pulmonary
function response was more evident in children with advanced CF
lung disease.
4.2. Clinical relevance
Easy and sensitive pulmonary function measures gain
increasing interest in early interventional research to maintain
respiratory health in CF [2,10]. We found that routine airway
clearance improves pulmonary function which is measurable
within the time frame of a single breath. The tidal DTG-SBWwas
easily applicable, highly repeatable within tests, and detectedCR Median (IQR) response Individual (n) response NCR
Flatter Steeper
65.3 −31.7 (−83.1; 3.2) 7 3
1.3 −0.6 (−1.6; 0.1) 7 3
0.5 0.1 (−0.2; 0.2) 1 0
4.1 −0.1 (−1.6; 0.6) 2 2
9.3 0.8 (0.5; 3) 0 0
Increase Decrease
0.3 −0.1 (−0.2; 0.0) 4 2
0.8 −0.2 (−0.6; 0.1) 4 2
0.4 −0.2 (−0.4; 0.0) 5 3
0.9 −0.4 (−0.8; 0) 5 3
halation and physiotherapy pulmonary function test (#3) are given as median and
ces were greater than the PFT's coefficient of repeatability (CR = 1.96 ∗ SD of
III) and increased spirometry indices reflect pulmonary function improvement.
hexafluoride); FEV1: forced expiratory volume in one second; and MEF25–75:
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clearance regimens in children. The effect size was significant
with respect to both predefined statistical (on the group level) and
clinical (on the individual level) thresholds (p- and CR-values).
SnIII from vital capacity N2-SBW and spirometry indices also
improved reassuring the clinical relevance. Statistically signifi-
cant changes in gas mixing following standardized interventions,
e.g. inhalation of hypertonic saline solution, have been shown
previously [2,10]. The current study adds that treatment response
can be measured easily in a single breath and may exceed
short-term variability of gas mixing efficiency, i.e. the CR from
repeated baseline tests, in individuals.
Most previous studies failed to detect effects of airway
clearance on pulmonary function [15,33]. Fuchs et al. [15] did
not find consistent changes in the lung clearance index (LCI), a
measure of global ventilation inhomogeneity, following PT.
Similarly, spirometry indices did not change. However, inhalation
prior to PT was not applied and 14 patients may have provided
less statistical power.
4.3. Physiological relevance
The DTG-SBW test differentiates specific ventilation inho-
mogeneity arising in pre-acinar lung regions where the diffusion–
convection front of He arises, and the proximal acinar airways
where the diffusion–convection front of SF6 arises. Secretions,
airway inflammation, remodeling and other factors may impair
the homogeneity and efficiency of ventilation distribution. Those
mechanisms may have influenced He and SF6 wash-in,
ventilation distribution, and subsequent washout of He and SF6
during the tidal DTG-SBW test.
Our data suggest that the combination of bronchodilator and
chest PT can immediately improve gas mixing. SnIIIDTG
z-scores significantly decreased. Poorly ventilated lung spaces
may have been recruited by the interventions and subsequently
altered gas mixing. We hypothesize that the observed dynamics
in gas mixing were mediated by the two major airway spaces
which can be characterized by gas transport mechanisms:
(i) convection dependent ventilation inhomogeneity in the central
airways, and (ii) diffusion–convection dependent ventilation
inhomogeneity near the acinar entrance [34]. Both convection
and diffusion–convection dependent ventilation inhomogeneities
give rise to the SnIIIN2 from vital capacity N2-SBW. SnIIIN2
from vital capacity N2-SBW, FEV1 and MEF25–75 systemically
improved after bronchodilation but did not further improve after
chest PT. Inhalation therapy may have primarily affected large
airways via bronchodilation leading to decreased convection
dependent ventilation inhomogeneity as well as increased
ventilatory capacity. However, SnIIIN2 from tidal N2-SBW and
SnIIICO2 from capnography as previously described [19] were
less able to measure immediate changes in gas mixing. The
improvement of SnIIIDTG following bronchodilator and chest PT
suggests that sputum mobilization improved gas mixing in more
peripheral air spaces where the convection–diffusion fronts of
SF6 and He arise.
Measures of specific ventilation heterogeneity, such as the
tidal DTG-SBW test, may be especially attractive to assesspulmonary function response in children with rather mild CF
lung disease. Airway clearance regimens may improve regional
ventilation heterogeneity in pre-acinar and acinar airways in
these children. These specific changes in gas mixing efficiency
can only be tracked by gasses of similar conductive but highly
differing diffusive properties, e.g. He and SF6 [35,36]. Given
the progression of CF lung disease with increasing involvement
of the central airways over time, the DTG-SBW could lose
sensitivity in more advanced lung disease as it measures only
regional ventilation heterogeneity. We found that in children
with more pronounced CF lung disease (decreased FEV1),
classical vital capacity N2-SBW and spirometry may detect
pulmonary function response better than DTG-SBW. However,
the numbers in the subgroups are small. The latter findings
should thus be interpreted cautiously and require further study.
4.4. Strengths and limitations
The high intra-test repeatability (ICC) of the tidal SnIIIDTG and
tidal SnIIIN2 shows, that these measures are reliable in children
whereas e.g. vital capacity SnIIIN2 is more variable despite the
standardized breathingmaneuver. Compared to the low variability
between tests (CR) in FEV1 in our study and previous reports
[32], higher variability of SnIII from both tidal and vital capacity
SBW tests was observed. The range of SnIII variability was well
in line from multiple SnIII indices (Scond, Sacin) derived from
MBW [22,24,37]. The current SnIII variability is likely to be
physiological as measurement noise has been shown to be low
[16,22].
The current pragmatic study incorporated airway clearance
regimens as done regularly at home. We did not aim to compare
any intervention but to assess the ability of four gas washout tests
to measure immediate pulmonary function response to routine
airway clearance. Further, chest PT is difficult to control, largely
depends on the patients' effort, and few studies exist showing
immediate efficacy [11,12,14]. The study rather demonstrated
real-world efficacy of routine airway clearance in children with
CF. Treatment response seems to be frequently heterogeneous
and may not exceed clinical thresholds [38]. The drawbacks of
the current and other pragmatic designs are that interventions are
not allocated randomly. However, pragmatic studies provide data
from less selected populations and findings are considered to be
clinically relevant [39]. We related observed treatment response
in individuals to what can be expected solely due to short-term
variability (CR). The CR provides 95% probability that the
observed changes in pulmonary function following intervention
were not due to chance. Changes greater than the CR were
evident in half of the children. However, it is less clear, if change
in gas mixing efficiency is predictive for sustained improvement
of pulmonary function in CF.
Singer et al. [16,17] developed an easy SBW protocol that is
especially attractive for measurements in children. This tidal
DTG-SBW requires a few normal tidal breaths. Previous SBW
protocols usually required exhalation to residual lung volume,
inhalation to vital capacity, and then exhalation back to residual
volume with predefined tidal flows. The LCI, the classical index
derived from standard MBW, reflects efficiency of tracer gas
573C. Abbas et al. / Journal of Cystic Fibrosis 12 (2013) 567–574clearance, a robust measure of overall ventilation heterogeneity.
However, standardMBWmay take up to 40 min in children [40].
The current setup is currently the first which has been
validated according to the ERS/ATS consensus on inert gas
washout testing [23]. The software enables online visual control
of signals and flow-volume curves as currently recommended. A
limitation of the DTG-SBW test is that SF6 is required, a potential
green house gas which is prohibited in some countries.5. Conclusion
Gasmixing efficiency improves upon routine airway clearance
regimens in childrenwith CF. The tidal DTG-SBW is a promising
test to assess gas mixing efficiency within the timeframe of
a single breath. The treatment response measured by the DTG-
SBW was significant based on both statistical and clinical
thresholds. The DTG-SBW seems especially sensitive to measure
pulmonary function response to chest PT in children with normal
FEV1. In children with more advanced CF lung disease and
decreased FEV1, spirometry and the classical vital capacity
N2-SBW may demonstrate bronchodilator effects. The tidal
DTG-SBW allows for easy and repeated assessments of gas
mixing efficiency, an outcome of growing interest in CF care.Disclosures
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